Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.
- Published In:
- The Lancet regional health. Europe, 59, 101499 (2025)
- Authors:
- Fadini, Gian Paolo(3), Giaccari, Andrea, Broglio, Fabio(8), Nollino, Laura, Fattor, Bruno, Anichini, Roberto, Meregalli, Giancarla, Avogaro, Angelo, Consoli, Agostino
- Database ID:
- RPEP-10879
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10879APA
Fadini, Gian Paolo; Giaccari, Andrea; Broglio, Fabio; Nollino, Laura; Fattor, Bruno; Anichini, Roberto; Meregalli, Giancarla; Avogaro, Angelo; Consoli, Agostino. (2025). Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.. The Lancet regional health. Europe, 59, 101499. https://doi.org/10.1016/j.lanepe.2025.101499
MLA
Fadini, Gian Paolo, et al. "Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.." The Lancet regional health. Europe, 2025. https://doi.org/10.1016/j.lanepe.2025.101499
RethinkPeptides
RethinkPeptides Research Database. "Type 2 diabetes remission after initiation of GLP-1 receptor..." RPEP-10879. Retrieved from https://rethinkpeptides.com/research/fadini-2025-type-2-diabetes-remission
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.